Results 111 to 120 of about 4,839 (128)

Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms. [PDF]

Clin Exp Med
Liang F, Liang X, Pan L, Jin Q, Deng J, Hong M, Wei W, Hao Z, Ren H, Wang H, Chen X.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen

Acta Haematologica, 2011
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), currently considered to originate from immature plasmacytoid dendritic cells (DC), is a rare and aggressive CD4+CD56+ neoplasm that frequently involves the skin and bone marrow. We present a case of an 80-year-old man with a CD4+CD56+ BPDCN that affected the orbital cavity and bone marrow.
Daichi, Inoue, Kyoko, Maruyama, Kazunari, Aoki, Seiji, Nagano, Hayato, Maruoka, Yukihiro, Imai, Kiminari, Ito, Takayuki, Ishikawa, Takayuki, Takahashi   +8 more
openaire   +2 more sources

Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67

British Journal of Haematology, 1993
Summary. A number of differentiation antigens on myeloid cells have been defined on the CD classification system by the four International Workshops on Human Leucocyte Differentiation Antigens. The distribution of eight of these antigens (CD13, CD14, CD16, CD31, CD36, CD65, CD66, CD67) have been studied in human tissues, with the aim of documenting ...
D, Bordessoule, M, Jones, K C, Gatter, D Y, Mason   +3 more
openaire   +2 more sources

CD13 regulates dendritic cell cross-presentation and t cell responses by inhibiting receptor-mediated antigen uptake (106.16)

The Journal of Immunology, 2012
Abstract Dendritic cell (DC) antigen cross-presentation is generally associated with immune responses to tumors and viral antigens and enhancing this process is a focus of tumor vaccine design. In this study, we found that the myeloid cell surface peptidase CD13 is highly and specifically expressed on the subset of DCs responsible for ...
Mallika Ghosh, Beata McAuliffe, Jaganathan Subramani, Sreyashi Basu, Linda H Shapiro   +4 more
openaire   +1 more source

Induction of myelo-monocytic My7 antigen (CD13) expression by interferon-α in basal cells of cutaneous T-cell lymphomas

British Journal of Dermatology, 1992
The My7 antigen that is expressed on the basal cells in normal skin and inflammatory disorders is absent in the lesions of cutaneous T-cell lymphoma (CTCL). Induction of My7 expression in basal cells in the cutaneous lesions of 12 patients with mycosis fungoides and three with Sézary syndrome treated with interferon-alpha 2a (IFN-alpha 2a) for 10 ...
B, Dreno, M, Fleischmann, S, Valard, W, Godefroy, B, Bureau, J F, Stadler, P, Litoux   +6 more
openaire   +2 more sources

Further investigations on the expression of HLA‐DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34± haematopoietic progenitor cells

British Journal of Haematology, 1993
Summary. We evaluated the HLA‐DR, CD33 and CD13 antigen expression on CD34± haematopoietic progenitor cells (HPC) isolated from the bone marrow (BM) and peripheral blood (PB) of normal donors. The majority of both BM and PB CD34± HPC expressed CD13 and HLA‐DR. The coexpression of CD34 and CD33 was found in a minor CD34± subset. After 7 d of culture in
PIERELLI, LUCA, L. Teofili, G. Menichella, C. Rumi, A. Paoloni, S. Iovino, P. L. Puggioni, G. Leone, B. Bizzi   +8 more
openaire   +2 more sources

Surface and cytoplasmic expression of CD2, CD13, and CD25 antigens in human T lymphotropic virus type I infected cell line. An immunoelectron microscopic study.

Laboratory investigation; a journal of technical methods and pathology, 1989
Immunoperoxidase electron microscopy revealed intracellular expression of CD2, CD13, and CD25 antigens in a unique human T lymphotropic virus type I infected cell line, TI-CL. This cell line is thought to be derived from cord mononuclear cells in the bifurcation stage of T cell and myelomonocytic lineage, based on cytochemical, immunologic, and ...
T, Kobayashi, H, Miwa, T, Uchida, N, Matsuoka, K, Kita, S, Shirakawa   +5 more
openaire   +2 more sources

B-cell prolymphocytic leukemia expressing CD13 antigen.

International journal of hematology, 1994
Although the expression of myeloid-associated antigen CD13 has been reported in aggressive B-cell chronic lymphocytic leukemia, its expression in other mature B-cell neoplasms appears to be rare. We report a 74-year-old female with B-cell prolymphocytic leukemia (B-PLL) expressing CD13 antigen. On admission, splenomegaly was noted.
A, Matsushita, K, Nagai, T, Ishikawa, E, Tatsumi, Y, Ohno, T, Takahashi   +5 more
openaire   +1 more source

CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging

European Journal of Nuclear Medicine and Molecular Imaging
Approximately 10% of prostate cancer (PCa) are prostate-specific membrane antigen (PSMA)-negative, leading to blind spots in PSMA-based diagnosis. This study aimed to identify a potential target for PSMA-negative PCa and preliminarily evaluate the feasibility of using radionuclide probe targeting the identified target for PCa diagnosis.Quantitative ...
Wei Tang, Ming Zhou, Chenxi Lu, Lin Qi, Ye Zhang, Yongxiang Tang, Xiaomei Gao, Shuo Hu, Yi Cai   +8 more
openaire   +2 more sources